Share chart Oramed Pharmaceuticals Inc.
Extended chart
Simple chart
About Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. занимается исследованием и разработкой фармацевтических растворов для лечения диабета и использования пероральных капсул или пилюль для доставки полипептидов. more detailsMain settings
| IPO date | 2006-04-21 |
|---|---|
| ISIN | US68403P2039 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | link |
| Change price per day: | 0% (2.12) |
|---|---|
| Change price per week: | -1.4% (2.15) |
| Change price per month: | -9.01% (2.33) |
| Change price per 3 month: | -1.4% (2.15) |
| Change price per half year: | -10.55% (2.37) |
| Change price per year: | -3.64% (2.2) |
| Change price per 3 year: | -52.57% (4.47) |
| Change price per 5 year: | -30.94% (3.07) |
| Change price per year to date: | -10.92% (2.38) |
Grade
Underestimation
| Title | Value | Grade |
|---|---|---|
| P/S | 71.65 | 1 |
| P/BV | 0.6712 | 10 |
| P/E | 17.38 | 7 |
Efficiency
| Title | Value | Grade |
|---|---|---|
| ROA, % | -10.14 | 0 |
| ROE, % | -12.29 | 0 |
| ROIC, % | 0 | 0 |
Dividends
| Title | Value | Grade |
|---|---|---|
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
|---|---|---|
| Debt/EBITDA | -0.0242 | 10 |
| Debt/Ratio | 0.0058 | 10 |
| Debt/Equity | 0.0683 | 10 |
Growth impulse
| Title | Value | Grade |
|---|---|---|
| Yield Revenue, % | -50.43 | 0 |
| Yield Ebitda, % | 9.88 | 2 |
| Yield EPS, % | -17.05 | 0 |
Main owners
| Institutions | Volume | Share, % |
|---|---|---|
| Bml Capital Management, LLC | 1 261 559 | 3.13 |
| Rathbones Group PLC | 289 803 | 0.72 |
| Two Sigma Advisers, LP | 165 600 | 0.41 |
| Goldman Sachs Group Inc | 153 618 | 0.38 |
| GSA Capital Partners LLP | 88 923 | 0.22 |
| Blackrock Inc. | 88 798 | 0.22 |
| ETF Managers Group, LLC | 68 940 | 0.17 |
| Morgan Stanley | 60 514 | 0.15 |
| State Street Corporation | 56 814 | 0.14 |
| Squarepoint Ops LLC | 52 844 | 0.13 |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Nadav Kidron Esq. | President, CEO & Executive Chairman | 754.3k | 1974 (51 year) |
| Dr. Miriam Kidron Ph.D. | Chief Scientific Officer & Director | 503.95k | 1940 (85 years) |
| Mr. Joshua Hexter | Chief Operating & Business Officer | 326.94k | 1970 (55 years) |
| Mr. Avraham Gabay | CFO, Treasurer & Secretary | 1985 (40 years) |
About company
Address: United States, New York. NY, 1185 Avenue of the Americas - Open in google maps, Open in yandex maps
Website: https://www.oramed.com
Website: https://www.oramed.com
